Paid Clinical Trials Detroit

Discover 1,876 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,876

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Detroit MI, Rochester NY, Frederick MD, Binghamton NYshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

MyeloMATCHComparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Livonia MI, Canton MI, Ypsilanti MI, Brighton MIshow 9 more

Code:

NCT06672146

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Decitabine and Cedazuridine

Enasidenib

Observational StudyStent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative

Recruiting

Sponsor:

University of Michigan

Location:

Ann Arbor MI, Brighton MI, Chelsea MI

Code:

NCT05866081

Conditions

Stone, Kidney

Stone Ureter

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Standard of care stent placement

No stent placement

Surveys

Gene TherapyGene Therapy for ACM Due to a PKP2 Pathogenic Variant

Recruiting

PHASE1

PHASE2

Sponsor:

Lexeo Therapeutics

Location:

Ann Arbor MI, Rochester NY, Baltimore MD, Charleston SCshow 1 more

Code:

NCT06109181

Conditions

Arrhythmogenic Cardiomyopathy

PKP2-ACM

PKP2-ARVC

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

LX2020

P-CD19CD20-ALLO1P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Recruiting

PHASE1

Sponsor:

Poseida Therapeutics, Inc.

Location:

Detroit MI, Cincinnati OH, Nashville TN, Chapel Hill NCshow 5 more

Code:

NCT06014762

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

High-grade B-cell Lymphoma

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Transformed Follicular Lymphoma (tFL)

Follicular Lymphoma Grade 3B

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

P-CD19CD20-ALLO1

Rimiducid

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Detroit MI, Farmington Hills MI, Cleveland OH, Torontoshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

GLIADEL vs. Stereotactic RadiosurgeryA Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting

PHASE2

Sponsor:

University of Nebraska

Location:

Detroit MI, Omaha NE

Code:

NCT04222062

Conditions

Brain Tumor - Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carmustine 7.7Mg Wafer

Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Detroit MI, Buffalo NY, Chicago IL, Indianapolis INshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

BomedemstatA Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Ann Arbor MI, Pittsburgh PA

Code:

NCT06351631

Conditions

Thrombocythemia, Essential

Primary Myelofibrosis

Myelofibrosis

Post-polycythemia Vera Myelofibrosis

Post-essential Thrombocythemia Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bomedemstat

Observational StudyProspective Controlled Study of Posttransplant Diabetes

Recruiting

Sponsor:

National Center for Research Resources (NCRR)

Location:

Ann Arbor MI

Code:

NCT00006331

Conditions

Diabetes Mellitus

Kidney Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

renal transplant

NTLA-2002HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Recruiting

PHASE3

Sponsor:

Intellia Therapeutics

Location:

Detriot MI, Columbus OH, Cincinnati OH, Hershey PAshow 13 more

Code:

NCT06634420

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

NTLA-2002

Normal Saline IV Administration